Time course of frontal somatosensory evoked potentials: Relation to L- dopa plasma levels and motor performance in PD

Neurology

Volumn 53, Issue 7, 1999, Pages 1451-1457

  Ulivelli, M ^a   Rossi, S ^a   Pasqualetti, P ^b,c   Rossini, P M ^b,c   Ghiglieri, O ^a   Passero, S ^a   Battistini, N ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b FATEBENEFRATELLI HOSPITAL   (Italy)

^c IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

Author keywords

L dopa; PD; Pharmacodynamics; Somatosensory evoked potentials

Indexed keywords

CARBIDOPA; LEVODOPA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; EVOKED SOMATOSENSORY RESPONSE; FEMALE; FRONTAL BONE; HUMAN; MALE; MEDIAN NERVE; MOTOR PERFORMANCE; NERVE CONDUCTION; NERVE STIMULATION; PREMOTOR CORTEX; PRIORITY JOURNAL; PULSE GENERATOR; REACTION TIME;

EID: 0032718426     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.53.7.1451     Document Type: Article

References (35)

1. Desmedt JE, Cheron G. Non-cephalic reference recording of early somatosensory evoked potentials to finger stimulation in aging normal man: differentiation of widespread N18 and contralateral N20 from the prerolandic P22 and N30 components. Electroencephalogr Clin Neurophysiol 1981;52:553-570.
2. Chiappa KH, Ropper AH. Evoked potentials in clinical medicine. N Engl J Med 1982;306:1140-1150, 1205-1211.
3. Rossini PM. N30 in PD. Neurology 1996;47:303-304. Letter.
4. Rossini PM, Babiloni F, Bernardi G, et al. Abnormalities of short-latency somatosensory evoked potentials in parkinsonian patients. Electroencephalogr Clin Neurophysiol 1989;74: 277-289.
5. Rossini PM, Paradiso C, Zarola F, et al. Brain excitability and long-latency muscular arm responses: non-invasive evaluation in healthy and parkinsonian subjects. Electroencephalogr Clin Neurophysiol 1991;81:454-465.
6. Cheron G, Piette T, Thiriaux A, Jacquy J, Godaux E. Somatosensory evoked potentials at rest and during movements in Parkinson's disease: evidence for a specific apomorphine effect on the frontal N30 wave. Electroencephalogr Clin Neurophysiol 1994;92:491-501.
7. Onofrj M, Fulgente T, Malatesta G, et al. The abnormality of N30 somatosensory evoked potential in idiopathic Parkinson's disease is unrelated to disease stage or clinical scores and insensitive to dopamine manipulations. Mov Disord 1995;10: 71-80.
8. Grosswasser Z, Kriss A, Dell S, Toshimiwal P, Halliday AM. Pattern VEPs, SEPs, BAEPs in Parkinson's disease. Electroencephalogr Clin Neurophysiol 1985;61:16-65.
9. Onofrj M, Ghilardi MF, Basciani M, Martinez-Tica J, Glover A. Attenuation of the early anterior negativity of median nerve somatosensory evoked potentials in the MPTP-treated monkey. Clin Neurophysiol 1990;20:283-293.
10. Huttunen J, Teravainen H. Pre- and post-central cortical somatosensory evoked potentials in hemiparkinsonism. Mov Disord 1993;4:430-436.
11. Garcia PA, Aminoff MJ, Goodin DS. The frontal N30 component of the median-derived SEP in patients with predominantly unilateral Parkinson's disease. Neurology 1995;45: 989-992.
12. Drory VE, Inzelberg R, Groozman GB, Korczyn AD. N30 somatosensory evoked potentials in patients with unilateral Parkinson's disease. Acta Neurol Scand 1998;97:73-76.
13. Rossini PM, Traversa R, Boccasena P, et al. Parkinson's disease and somatosensory evoked potentials: apomorphine-induced transient potentiation of frontal components. Neurology 1993;43:2495-2500.
14. Mauguière F, Broussolle E, Isnard J. Apomorphine-induced relief of the akinetic-rigid syndrome and early median nerve somatosensory evoked potentials (SEPs) in Parkinson's disease. Electroencephalogr Clin Neurophysiol 1993;88:243-254.
15. Fahn S, Elston RL, members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB, eds. Recent developments in Parkinson's disease, vol. 2. New York: MacMillan, 1987:153-163.
16. Contin M, Riva R, Martinelli P, et al. Response to standard oral levodopa test in parkinsonian patients with motor fluctuations. Clin Neuropharmacol 1990;13:19-28.
17. Rossini PM, Caramia MD, Bassetti A, Pasqualetti A, Tecchio F, Bernardi G. Somatosensory evoked potentials during ideation and execution of individual finger movements following 'internal' or 'external' cues. Muscle Nerve 1996;19:191-202.
18. Rossini PM, Babiloni F, Babiloni C, Ambrosini A, Onorati P, Urbano A. Topography of spatially enhanced human short-latency somatosensory evoked potentials. Neuroreport 1997;8: 991-994.
19. Mauguière F, Desmedt JE, Courjon J. Astereognosis and dissociated loss of frontal and parietal components of somatosensory evoked potentials in hemispheric lesions. Brain 1983;106: 271-311.
20. Gutling E, Gonser A, Regard M, Glinz W, Landis T. Dissociation of frontal and parietal components of somatosensory evoked potentials in severe head injury. Electroencephalogr Clin Neurophysiol 1993;88:369-376.
21. Desmedt JE, Cheron G. Somatosensory evoked potentials to finger stimulation in healthy octogenarians and in young adults: wave forms, scalp topography and transit times of parietal and frontal components. Electroencephalogr Clin Neurophysiol 1980;50:404-425.
22. Noguchi Y, Yamada T, Yeh M, et al. Dissociated changes of frontal and parietal somatosensory evoked potentials in sleep. Neurology 1995;45:154-160.
23. Ebner A, Deuschl G. Frontal and parietal components of enhanced somatosensory evoked potentials: a comparison between pathological and pharmacologically induced conditions. Electroencephalogr Clin Neurophysiol 1988;71:170-179.
24. Insola A, Rossi S, Mazzone P, Pasqualetti P. Parallel processing of sensory inputs: evidence from parkinsonians with thalamic stimulators. Clin Neurophysiol 1999;110:146-151.
25. Cohen LG, Starr A. Localization, timing and specificity of gating of somatosensory evoked potentials during active movement in man. Brain 1987;110:451-467.
26. Cheron G, Borenstein S. Specific gating of the early somatosensory evoked potentials during active movement. Electroencephalogr Clin Neurophysiol 1987;67:537-548.
27. Berger B, Trottier S, Verney C, Gaspar P, Alvarez C. Regional and laminar distribution of the dopamine and serotonin in macaque cerebral cortex. J Comp Neurol 1988;273:99-119.
28. Gaspar P, Duyckaert C, Alvarez C, Javoy-Agid F, Berger B. Alterations of dopaminergic and noradrenergic innervations in motor cortex in Parkinson's disease. Ann Neurol 1991;30: 365-374.
29. Permutter JS, Raichle ME. Regional blood flow in hemiparkinsonism. Neurology 1985;35:1127-1134.
30. Myberg HS, Starkstein SE, Sadzot B, et al. Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease. Ann Neurol 1990;28:57-64.
31. Jenkins IH, Fernandez W, Playford ED, et al. Impaired activation of supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine. Ann Neurol 1992;32:749-757.
32. Rascol O, Sabatini U, Chollet F, et al. Supplementary and primary motor area activity in Parkinson's disease: regional cerebral blood flow changes during finger movements and effects of apomorphine. Arch Neurol 1992;49:114-148.
33. Rascol O, Sabatini U, Brefel C, et al. Cortical motor overactivation in parkinsonian patients with L-dopa-induced peak-dose dyskinesia. Brain 1998;121:527-533.
34. Alexander GE, De Long MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986;9:357-381.
35. Alexander GE, Cutcher MD, De Long MR. Basal gangliathalamo cortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Prog Brain Res 1990;85:119-146.